A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.

CESB directors

Twitter

Podcasts

WUKY's "UK Perspectives" Talks about UK in Appalachia
UK at the Half: $7 Million Grant to Fight Lung Cancer
The Importance of Teamwork with Dr. Lisa Cassis